Purchase Order 75N93021P00115

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for plant and animal eukaryotic mRNA sequencing on March 16, 2022, with a ceiling value of $11,947.00 and ultimate completion date of April 15, 2022. Novogene is a minority-owned small business. Work is performed in Sacramento, California. The order is firm fixed price with no set-aside applied.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. on November 17, 2020, for mRNA sequencing services for innate immunity analysis, with a firm fixed price ceiling of $30,240. Novogene Corporation Inc. is a minority-owned small business. Work is performed in Sacramento, California. The order calls for mRNA sequencing services supporting innate immunity research. The ultimate completion date is January 15, 2021. The award resulted...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Novogene Corporation Inc. for $56,640 on August 19, 2021, for premade libraries and lane sequencing for NovaSeq PE 150 sequencing equipment. Novogene is a minority-owned small business based in Sacramento, California. Work is performed in Sacramento, California. The ultimate completion date is September 29, 2022. The solicitation was posted August 4, 2021, with a due date of August 11, 2021, and award date of...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $11,820 firm fixed-price purchase order to Novogene Corporation Inc., a Sacramento, California-based minority-owned small business specializing in genomic sequencing and bioinformatics services. Awarded on September 9, 2021, with an ultimate completion date of September 28, 2022, this contract involved no small business set-aside. The award was issued to administratively de-obligate unexpended and expiring fiscal year...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...

This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...

<p>The National Institute on Aging awarded a purchase order to Novogene Corporation Inc. for $19,370.00 on March 2, 2021, for human mRNA sequencing services. The order, a firm fixed-price acquisition with no set-aside, is scheduled for completion by June 4, 2021. Work is performed in Chula Vista, California. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services.</p>

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies,...

This is a firm fixed-price purchase order awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $15,900.00 contract will provide plant and animal ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) services utilizing the Illumina NovaSeq PE150 platform. The work will be performed in Sacramento, California and is expected to be...

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract, valued at $14,925.00, is for human messenger RNA (mRNA) sequencing services. The contract has an ultimate completion date of December 4, 2020 and was awarded on June 26, 2019. Novogene is a provider of advanced genomic sequencing and bioinformatics services, and has secured multiple...